The burden of neuropathic pain: A systematic review and meta-analysis of health utilities

Attal, 2006, EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain., Eur J Neurol, 13, 1153, 10.1111/j.1468-1331.2006.01511.x Bremner, 2007, A review and meta-analysis of prostate cancer utilities., Med Decis Making, 27, 288, 10.1177/0272989X07300604 Clayson, 2006, A comparative review of health-related quality-of-life measures for use in HIVAIDS clinical trials., Pharmacoeconomics, 24, 751, 10.2165/00019053-200624080-00003 Cruccu, 2007, EFNS guidelines on neurostimulation therapy for neuropathic pain., Eur J Neurol, 14, 952, 10.1111/j.1468-1331.2007.01916.x DerSimonsen, 1986, Meta analysis in clinical trials., Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Detsky, 2007, Relevance of cost-effectiveness analysis to clinicians and policy makers., JAMA, 298, 221, 10.1001/jama.298.2.221 Efficace, 2008, Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making., Eur J Cancer, 44, 1497, 10.1016/j.ejca.2008.03.017 Jensen, 2007, The impact of neuropathic pain on health-related quality of life: review and implications., Neurology, 28, 1178, 10.1212/01.wnl.0000259085.61898.9e Johnson, 2000, Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta Canada., Med Care, 38, 115, 10.1097/00005650-200001000-00013 Luo, 2005, Self-reported health status of the general adult US population as assessed by the EQ-5D and health utilities index., Med Care, 43, 1078, 10.1097/01.mlr.0000182493.57090.c1 McDermott, 2006, The burden of neuropathic pain: results from a cross-sectional survey., Eur J Pain, 10, 127, 10.1016/j.ejpain.2005.01.014 Manca, 2008, Quality of life, resource consumption and costs of spinal cord simulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial)., Eur J Pain, 12, 1047, 10.1016/j.ejpain.2008.01.014 Meyer-Rosberg, 2001, A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain., Eur J Pain, 5, 391, 10.1053/eujp.2001.0260 Moher, 1999, Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses., Lancet, 354, 1896, 10.1016/S0140-6736(99)04149-5 OConnor, 2009, Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy., Pharmacoeconomics, 2, 95, 10.2165/00019053-200927020-00002 Parkin, 1998, A cost-utility analysis of interferon beta for multiple sclerosis., Health Technol Assess, 2, iii, 10.3310/hta2040 Pickard, 2007, Health utilities using the EQ-5D in studies of cancer., Pharmacoeconomics, 25, 365, 10.2165/00019053-200725050-00002 Treede, 2008, Neuropathic pain: redefinition and a grading system for clinical and research purposes., Neurology, 70, 1830, 10.1212/01.wnl.0000282763.29778.59